Cargando…
Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s Disease
BACKGROUND: Idiopathic Parkinson’s disease (IPD) and LRRK2-associated PD (LRRK2-PD) might be expected to differ clinically since the neuropathological substrate of LRRK2-PD is heterogeneous. The range and severity of extra-nigral nonmotor features associated with LRRK2 mutations is also not well-def...
Autores principales: | Gaig, Carles, Vilas, Dolores, Infante, Jon, Sierra, María, García-Gorostiaga, Inés, Buongiorno, Mariateresa, Ezquerra, Mario, Martí, Maria José, Valldeoriola, Francesc, Aguilar, Miquel, Calopa, Matilde, Hernandez-Vara, Jorge, Tolosa, Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201457/ https://www.ncbi.nlm.nih.gov/pubmed/25330404 http://dx.doi.org/10.1371/journal.pone.0108982 |
Ejemplares similares
-
(123)I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations
por: Valldeoriola, Francesc, et al.
Publicado: (2011) -
Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers
por: Pont-Sunyer, Claustre, et al.
Publicado: (2015) -
Transcriptome analysis in LRRK2 and idiopathic Parkinson’s disease at different glucose levels
por: Fernández-Santiago, Rubén, et al.
Publicado: (2021) -
Brainstem neuromelanin and iron MRI reveals a precise signature for idiopathic and LRRK2 Parkinson’s disease
por: Martínez, Martín, et al.
Publicado: (2023) -
Increased Phospho‐AKT in Blood Cells from
LRRK2 G2019S Mutation Carriers
por: Garrido, Alicia, et al.
Publicado: (2022)